Later this quarter, Tris is scheduled to report data from a human abuse potential study, as well as the results of ALLEVIATE-2, a companion phase 3 study in patients after bunionectomy surgery.
Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback